Federated Hermes Portfolio holdings
Federated Hermes is an investment manager that runs mutual funds, ETFs and other portfolios across stocks, bonds, alternative and private markets and liquidity management. It began in 1955 as Federated Investors, set up by three high school classmates: John F. Donahue, Thomas J. Donnelly and Richard B. Fisher. In 2018 the firm bought a majority stake in Hermes Fund Managers, which ran Hermes Investment Management, from the BT Pension Scheme. In 2020 Federated Investors renamed itself Federated Hermes. Its clients include corporations, government entities, insurance companies, foundations, endowments, banks and brokerages.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$436M |
| 2 |
Regions Financial
RF
|
+$313M |
| 3 |
Automatic Data Processing
ADP
|
+$289M |
| 4 |
Intuit
INTU
|
+$288M |
| 5 |
Netflix
NFLX
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 2 |
Teradyne
TER
|
+$320M |
| 3 |
Truist Financial
TFC
|
+$313M |
| 4 |
UnitedHealth
UNH
|
+$287M |
| 5 |
Huntington Bancshares
HBAN
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.03% |
| 2 | Healthcare | 13.59% |
| 3 | Industrials | 13.09% |
| 4 | Financials | 10.33% |
| 5 | Consumer Discretionary | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
326
Palomar
PLMR
$3.69B
| $38.2M | 0.06% |
302,615
-6,138
| -2% | -$723K |
2019 Q3
27 quarters
|
|
327
Elanco Animal Health
ELAN
$11.5B
| $38M | 0.05% |
1,543,944
-879,406
| -36% | -$20.3M |
2022 Q3
15 quarters
|
|
328
Tango Therapeutics
TNGX
$3.83B
| $38M | 0.05% |
1,214,613
+1,214,259
| +343,011% | +$30M |
2025 Q1
5 quarters
|
|
329
Outfront Media
OUT
$5.64B
| $37.7M | 0.05% |
1,151,175
+19,669
| +2% | +$610K |
2024 Q3
7 quarters
|
|
330
Brunswick
BC
$4.88B
| $37.7M | 0.05% |
447,493
-25,195
| -5% | -$2.02M |
2013 Q2
52 quarters
|
|
331
Semtech
SMTC
$11.9B
| $37.6M | 0.05% |
232,314
+98,244
| +73% | +$12.8M |
2024 Q2
8 quarters
|
|
332
Steris
STE
$22.1B
| $37.6M | 0.05% |
178,383
-15,121
| -8% | -$3.24M |
2013 Q2
52 quarters
|
|
333
Smurfit Westrock
SW
$22.6B
| $37.5M | 0.05% |
811,008
+778,980
| +2,432% | +$32.2M |
2024 Q3
7 quarters
|
|
334
ConocoPhillips
COP
$185B
| $37.5M | 0.05% |
360,619
+8,826
| +3% | +$1.05M |
2013 Q2
52 quarters
|
|
335
Dollar Tree
DLTR
$25.1B
| $37M | 0.05% |
305,681
-492,393
| -62% | -$51.2M |
2013 Q2
52 quarters
|
|
336
Cardinal Infrastructure Group
CDNL
$327M
| $37M | 0.05% |
392,348
+33,400
| +9% | +$1.92M |
2025 Q4
2 quarters
|
|
337
Eaton
ETN
$144B
| $36.9M | 0.05% |
86,552
-4,397
| -5% | -$1.77M |
2013 Q2
52 quarters
|
|
338
UMB Financial
UMBF
$10.2B
| $36.5M | 0.05% |
255,948
+85,274
| +50% | +$11M |
2016 Q2
40 quarters
|
|
339
Zurn Elkay Water Solutions
ZWS
$7.4B
| $36.3M | 0.05% |
718,205
+199,852
| +39% | +$9.8M |
2024 Q4
6 quarters
|
|
340
Chime Financial
CHYM
$10.6B
| $36.3M | 0.05% |
1,771,652
+202,769
| +13% | +$3.94M |
2025 Q2
4 quarters
|
|
341
Janux Therapeutics
JANX
$1.07B
| $36.1M | 0.05% |
2,352,927
+2,298,727
| +4,241% | +$33.3M |
2025 Q4
2 quarters
|
|
342
Hamilton Insurance Group
HG
$3.46B
| $36.1M | 0.05% |
1,063,985
+118,323
| +13% | +$3.71M |
2024 Q2
8 quarters
|
|
343
Aaon
AAON
$5.56B
| $36M | 0.05% |
283,669
-193,304
| -41% | -$22.6M |
2024 Q2
8 quarters
|
|
344
ICU Medical
ICUI
$4.1B
| $35.7M | 0.05% |
243,438
-14,060
| -5% | -$1.83M |
2014 Q4
46 quarters
|
|
345
Qnity Electronics Inc
Q
$24.4B
| $35.6M | 0.05% |
217,832
+216,954
| +24,710% | +$32M |
2025 Q4
2 quarters
|
|
346
CenterPoint Energy
CNP
$28.1B
| $35.4M | 0.05% |
804,253
-95,198
| -11% | -$4.08M |
2013 Q2
52 quarters
|
|
347
Dutch Bros
BROS
$5.91B
| $35.4M | 0.05% |
492,783
-117,315
| -19% | -$6.73M |
2021 Q3
19 quarters
|
|
348
Freeport-McMoran
FCX
$89.7B
| $35.2M | 0.05% |
560,126
+258,460
| +86% | +$16.6M |
2020 Q2
24 quarters
|
|
349
Vaxcyte
PCVX
$9.8B
| $34.9M | 0.05% |
601,161
+34,333
| +6% | +$1.86M |
2025 Q2
4 quarters
|
|
350
Halliburton
HAL
$29.9B
| $34.9M | 0.05% |
1,029,004
-239,450
| -19% | -$9.36M |
2013 Q2
52 quarters
|
|
Similar funds
Federated Hermes's Q2 2026 Portfolio in Review
As of Q2 2026, Federated Hermes held 2,221 positions worth $69.6B, up 13% from $61.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2026 filing shows 173 new, 863 increased, 913 reduced and 183 closed positions. Its largest new stake was AngloGold Ashanti: 2,040,755 shares worth $165M. The largest sale was Alphabet (Google) Class A, an estimated $390M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.
- Federated Hermes's largest Q2 2026 buy was AngloGold Ashanti: 2,040,755 shares worth $165M.
- Federated Hermes added most to Apple in Q2 2026, an estimated $436M increase.
- Federated Hermes's biggest Q2 2026 reduction was Alphabet (Google) Class A, cutting an estimated $390M.
- Federated Hermes fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $81.4M.
- Federated Hermes's ten largest holdings make up 16% of its $69.6B portfolio in Q2 2026.
- Federated Hermes opened 173 new positions and closed 183 in Q2 2026.
- Federated Hermes's portfolio value rose 13% quarter-over-quarter to $69.6B.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.